Leverage collaboration with device partners to create more standardized and convenient disease management tools

Activation
Prevention
Diagnosis
Treatment
Follow-up

Activation
Prevention
Diagnosis
Treatment
Follow-up
AstraZeneca China and the Wuxi government in partnership with device company Omron jointly initiatied a platform to create China MMC (metabolic management center). MMC is an integrated solution providing diabetic patients with a 1-stop diagnosis and treatment management platform. It allows to check-up all diabetes complications in just 25 minutes, and provide 51% increase in glycemic control rate of patients. It already benefitted hundreds of thousands of patients in China with an objective to reach over 10 million T2D patients and reduce T2D complications by 10% in 10 years.
KPI suggestion: # of patients served; reduction in T2D complications

Low Touch


Patient convenience


Ecosystems


Technology Enabled


Access

One step closer to meaningful innovation

Keep yourself in the know, get our Newsletter

Let's get in touch!

After you fill in this form, one of our experts will reach out and talk to you.